Search results for "assessment"

showing 10 items of 5125 documents

Morbid risks for major disorders and frequencies of personality disorders among spouses of psychiatric inpatients and controls

1993

Three hundred fifty-three psychiatric inpatients and their 192 living spouses and 98 control subjects and their 54 living spouses were examined and interviewed for affective, schizoaffective, schizophrenic (Research Diagnostic Criteria [RDC]), and personality disorders (DSM-III-R) using the Lifetime Version of the Schedule for Affective Disorders and Schizophrenia (SADS-L) and the Structured Clinical Interview for DSM-III-Personality Disorders (SCID). The morbid risks of spouses for unipolar depression were between .15 and .25, and those for other major disorders were below .03. The morbid risks of spouses of bipolar patients for unipolar depression exceeded those of other spouses by 50% wi…

AdultMalemedicine.medical_specialtyBipolar DisorderPsychometricslcsh:RC435-571media_common.quotation_subjectResearch Diagnostic CriteriaPersonality AssessmentSocial EnvironmentPersonality DisordersRisk Factorslcsh:Psychiatrymental disordersmedicinePersonalityHumansMarriagePsychiatryDepression (differential diagnoses)media_commonAgedDepressive DisorderMental DisordersSchedule for Affective Disorders and SchizophreniaMiddle Agedmedicine.diseasePersonality disordersHospitalizationPsychiatry and Mental healthClinical PsychologyPsychotic DisordersSpouseSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyPsychologyClinical psychologyComprehensive Psychiatry
researchProduct

Erectile dysfunction is associated with low total serum testosterone levels and impaired flow-mediated vasodilation in intermediate risk men accordin…

2015

Background: The role erectile dysfunction (ED) coupled with low testosterone levels as early markers of atherosclerosis is not well understood. Objectives: To analyze the relationship between serum testosterone levels with both ED and brachial artery flow-mediated vasodilation (FMD), in a primary prevention sample of men. Methods: We enrolled 802 asymptomatic, intermediate CV risk patients, according to the Framingham Risk Score, aged 40e80 years, who underwent the ultrasound examination of FMD, the evaluation of ED and the assessment of total serum testosterone levels. Results: Testosterone levels correlated both with FMD (r ¼ 0.85; p < 0.0001) and IIEF-5 score (rs ¼ 0.65; p < 0.0001…

AdultMalemedicine.medical_specialtyBrachial ArteryFlow mediated vasodilationRisk AssessmentSeverity of Illness IndexAsymptomaticSettore MED/24 - UrologiaPeripheral Arterial DiseaseRisk Factorsmedicine.arteryInternal medicineDiabetes mellitusOdds RatioHumansMedicineTestosteroneErectile dysfunctionBrachial arteryAgedAged 80 and overSerum testosterone levelsChi-Square DistributionFramingham Risk Scorebusiness.industryEndothelial functionTestosterone (patch)Odds ratioMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareVasodilationLogistic ModelsEndocrinologyErectile dysfunctionRegional Blood FlowMultivariate AnalysisLinear ModelsCardiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexBiomarkersAtherosclerosis
researchProduct

Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular weight heparin.

2009

Introduction: We tested the efficacy and safety of fixed doses of Low-Molecular Weight Heparin (LMWH) in patients requiring interruption of Vitamin-k Antagonist (VKA) because of invasive procedures Methodology: Pre-operatively, patients discontinued VKA 5 +/- 1days; in those at low-risk for thrombosis, LMWH was given at a prophylactic dosage of 3.800 U.I. (nadroparin) or 4.000 U.I. (enoxaparin) anti-FXa once daily the night before the procedure. In patients at high-risk for thrombosis, LMWH was started early after VKA cessation and given at fixed sub-therapeutic doses (3.800 or 4.000 UI anti-FXa twice daily) until surgery. Post-operatively, LMWH was reinitiated 12 hours after procedure whil…

AdultMalemedicine.medical_specialtyBridging low molecular weight heparinTime FactorsVitamin Kmedicine.drug_classLow molecular weight heparinAdministration OralPostoperative HemorrhageRisk AssessmentDrug Administration ScheduleSettore MED/15 - Malattie Del SangueRisk FactorsThromboembolismmedicineHumansProspective StudiesEnoxaparinProspective cohort studyAgedAged 80 and overbusiness.industryIncidence (epidemiology)WarfarinAnticoagulantsNadroparinHematologyHeparinHeparin Low-Molecular-WeightMiddle Agedmedicine.diseaseThrombosisConfidence intervalSurgeryLow Molecular Weight Heparin Fixed doses Chronic oral anticoagulation perioperative bridgingAnesthesiaSurgical Procedures OperativeNadroparinFeasibility StudiesFemaleWarfarinbusinessmedicine.drugFactor Xa Inhibitors
researchProduct

Right bundle branch block and SIQIII-type patterns for risk stratification in acute pulmonary embolism.

2016

Abstract Introduction Risk stratification in acute pulmonary embolism (PE) is crucial for identification of patients with poor prognosis. We aimed to investigate the ECG alterations of right bundle branch block (RBBB) and S I Q III -type patterns for risk stratification in acute PE. Materials and methods Retrospective analysis of PE patients, treated in the Internal Medicine Department, was performed. Patients with RBBB and/or S I Q III -type were compared with those without both patterns. Logistic regression models for association between these ECG alterations and respectively right ventricular dysfunction (RVD), high-risk PE status and myocardial injury were computed. Results 175 patients…

AdultMalemedicine.medical_specialtyBundle-Branch BlockComorbidityRisk AssessmentSensitivity and SpecificityElectrocardiographyInternal medicineGermanyHeart rateTroponin IMedicineHumansDiagnosis Computer-AssistedAgedBundle branch blockmedicine.diagnostic_testbiologybusiness.industryVentilation/perfusion scanIncidenceReproducibility of ResultsRight bundle branch blockMiddle Agedmedicine.diseaseTroponinPulmonary embolismCausalityAcute Diseasebiology.proteinCardiologyFemaleCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismElectrocardiographyJournal of electrocardiology
researchProduct

An Eighteen-Minute Submaximal Exercise Test to Assess Cardiac Fitness in Response to Aerobic Training

2018

Romagnoli, M, Alis, R, Sanchis-Gomar, F, Lippi, G, and Arduini, A. An 18-minute submaximal exercise test to assess cardiac fitness in response to aerobic training. J Strength Cond Res 32(10): 2846-2852, 2018-We aimed to evaluate the utility of a submaximal heart rate recovery (HRR) test to monitor changes in cardiac fitness after aerobic training. Twenty healthy subjects were assigned to a control (n = 10) or a training (n = 10) group. Subjects in the training group performed 8 weeks of bicycle training, followed by 8 weeks of detraining. Heart rate recovery was assessed after exercises at 65% and 80% HRmax. The HRR test was performed at weeks 0 (W0), 4 (W4), 8 (W8), and 16 (W16) in the tra…

AdultMalemedicine.medical_specialtyCardiac FitnessPhysical Therapy Sports Therapy and RehabilitationSubmaximal exerciseRecovery periodHeart RateHeart ratemedicineHumansAerobic exerciseAerobic TrainingOrthopedics and Sports MedicineExercisebusiness.industryAMAXHealthy subjectsGeneral MedicineMiddle AgedTest (assessment)Highly sensitiveExercise Cardiac Fitness Aerobic TrainingCardiorespiratory FitnessExercise TestPhysical therapyFemalebusinesshuman activitiesPhysical Conditioning HumanJournal of Strength and Conditioning Research
researchProduct

Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain.

2006

Little is known about the prognostic value of leukocyte count on admission for patients with chest pain. In total, 1,461 patients who presented to the emergency department with non–ST-segment elevation chest pain were studied by clinical history, electrocardiography, serial troponin I determination, and leukocyte count on admission. End points were 1-year mortality and major events (mortality or infarction). Overall patient distribution by quartiles of leukocyte count showed increased mortality (6%, 7%, 6%, and 17%, p = 0.0001) and major events (13%, 13%, 15%, and 24%, p = 0.0001) in the fourth quartile. After adjustment for other risk factors, the fourth quartile cut-off value (>10,000 cel…

AdultMalemedicine.medical_specialtyChest PainMyocardial InfarctionChest painElectrocardiographyLeukocyte CountPatient AdmissionWhite blood cellInternal medicineTroponin IOutcome Assessment Health CareDiabetes MellitusMedicineST segmentHumansMyocardial infarctionAgedST depressionAged 80 and overbusiness.industryST elevationHazard ratioTroponin IAge FactorsMiddle Agedmedicine.diseasePrognosismedicine.anatomical_structureSpainMultivariate AnalysisCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessEmergency Service HospitalFollow-Up StudiesThe American journal of cardiology
researchProduct

Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation…

2017

Abstract Background Adjuvant chemotherapy is controversial in patients with locally advanced rectal cancer after preoperative chemoradiation. Valentini et al developed 3 nomograms (VN) to predict outcomes in these patients. The neoadjuvant rectal score (NAR) was developed after VN to predict survival. We aimed to validate these tools in a retrospective cohort at an academic institution. Patients and Methods VN and the NAR were applied to 158 consecutive patients with locally advanced rectal cancer treated with chemoradiation followed by surgery. According to the score, they were divided into low, intermediate, or high risk of relapse or death. For statistical analysis, we performed Kaplan-M…

AdultMalemedicine.medical_specialtyColorectal cancermedicine.medical_treatmentRectal neoplasms prognosisLocally advancedUrologyKaplan-Meier EstimateRisk AssessmentAdjuvant; Chemotherapy; Rectal neoplasms prognosis; Oncology; GastroenterologyDisease-Free Survival03 medical and health sciences0302 clinical medicinemedicineChemotherapyHumans030212 general & internal medicineAdjuvantSettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIAAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesAged 80 and overChemotherapyRectal NeoplasmsProportional hazards modelbusiness.industryHazard ratioGastroenterologyRetrospective cohort studyChemoradiotherapy AdjuvantMiddle AgedNomogrammedicine.diseaseNeoadjuvant TherapySurgeryNomogramsTreatment OutcomeOncology030220 oncology & carcinogenesisFemaleRisk assessmentbusinessClinical Colorectal Cancer
researchProduct

Resovist enhanced MR imaging of the liver: Does quantitative assessment help in focal lesion classification and characterization?

2009

Purpose: To improve characterization of focal liver lesions by a prospective quantitative analysis of percentage signal intensity change, in dynamic and late phases after slow (0.5 mL/s) Resovist administration. Materials and Methods: Seventy-three patients were submitted on clinical indication to MR examination with Resovist. Signal intensity of 92 detected focal lesions (5–80 mm) were measured with regions of interest and normalized to paravertebral muscle in arterial, portal, equilibrium and T1/T2 late phases, by two observers in conference. Five values of percentage variations per patient were obtained and statistically evaluated. Results: The enhancement obtained on dynamic study is mo…

AdultMalemedicine.medical_specialtyContrast MediaFerric CompoundsHemangiomaFocal lesionLate phaseImage Processing Computer-AssistedmedicineQuantitative assessmentHumansCutoffRadiology Nuclear Medicine and imagingMagnetite Nanoparticlesfocal liver lesions; Ferucarbotran; liver MRI; quantitative evaluation; Resovist; superparamagnetic iron oxide (SPIO)AgedAged 80 and overReceiver operating characteristicbusiness.industryReproducibility of ResultsDextransMiddle Agedmedicine.diseaseMagnetic Resonance ImagingMr imagingFerrosoferric OxideLiverROC CurveFemaleRadiologybusinessArea under the roc curveJournal of Magnetic Resonance Imaging
researchProduct

Smoking in COPD Patients: A New Clinical Phenotype?

2017

AdultMalemedicine.medical_specialtyCopd patientsmedicine.medical_treatmentMEDLINEPulmonary diseaseSymptom assessmentPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineForced Expiratory VolumeInternal medicinePrevalencemedicineHumans030212 general & internal medicineClinical phenotypeAgedAged 80 and overbusiness.industrySmokingGeneral MedicineMiddle AgedPhenotypePhenotype030228 respiratory systemSpainSmoking cessationFemaleSmoking CessationSymptom AssessmentbusinessArchivos de Bronconeumología (English Edition)
researchProduct

The distribution of whole blood viscosity, its determinants and relationship with arterial blood pressure in the community: cross-sectional analysis …

2015

Background: Blood viscosity has a role in modulating cardiovascular homeostasis; changes in this parameter have been associated with cardiovascular mortality and morbidity. However, it remains unclear whether these changes are (1) involved in the pathophysiology of disease, (2) an epiphenomenon, or (3) the expression of counterregulatory mechanisms. We report data on the normal values of blood viscosity and its association with cardiovascular risk factors, prevalent cardiovascular disease, and blood pressure in a large population-based cohort study. Methods and results: Viscosity was calculated using validated formulae and its associations were explored in 15,010 participants (mean 55.0, mi…

AdultMalemedicine.medical_specialtyCross-sectional studyBlood viscosityDiseaseCoronary Artery DiseaseRisk AssessmentReference ValuesRisk FactorsInternal medicineGermanymedicinePrevalenceHumansPharmacology (medical)Arterial PressureAgedHeart Failurebusiness.industryWhole blood viscosityRegression analysisMiddle AgedBlood ViscosityHealth SurveysPathophysiologySurgeryBlood pressureCross-Sectional StudiesLogistic ModelsCardiovascular DiseasesCohortCardiologyLinear ModelsFemaleCardiology and Cardiovascular MedicinebusinessTherapeutic advances in cardiovascular disease
researchProduct